Australia's largest stock trading and investment forum Australia's #1 stock forumIXC peaked at $1. 5¢ Sentiment: Hold Disclosure: Held IXC Valuation Report MST. ASX - By Stock. . Zillow has 23383 homes for sale in British Columbia. ASX - Day Trading. Ceasing to be a substantial holder. @FullMoonFever Another chart request if you are up for it please thanks in advance, page-6. IXC Price at posting: 79. I see it at perhaps $5 prior to readout. Share “Exercise Price Subject to paragraph (j), the amount payable upon exercise of each Option will be the 50% premium to the 30 day VWAP immediately prior to the Meeting (Exercise Price). The announcement was certainly a setback but we're not dead in. rights. ASX - Day TradingInvex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical. ASX - Day Trading. @FullMoonFever Another chart request if you are up for it please thanks in advance, page-8. Both approaches can work, but it is not wise to confuse the two. Of course, IXC’s BoD need to win back credibility for the market to more fairly value IXC’s TBI ODD… Having gone through the roller-coaster over the past one week, with my emotions now settled – I will be (slowly) buying-up in. ASX - Short Term Trading. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical. 6B TAM that is unencumbered and a 55% peer average neurology success rate from Phase 3!IXC although only the 1 indication has already raised the sufficient cash to go all the way, they are in phase 3 trials, they have a time line and are full steam ahead. ASX - Day TradingAt the request of a few posters who want to start afresh, welcome to the IXC charting thread going forward!If you're a poster who is inclined to track TA,. ASX - By Stock. Wouldn’t surprised me if they turn this company into something else if he keeps buyingCreated with Sketch. But since the cash holding is double the market cap, there most likely more upside than down side. Created with Sketch. Last updated 15. 7% #asx #ausbiz 23 Jun 2023 06:06:11Not been following IXC but it seems that this Orphan Drug Designation for TBI now have $0 value due to the other Phase III trial update and the company is. Forums. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical development Company with issued patents and multiple orphan drug designations focused on the repurposing of an already approved drug, Exenatide, for efficacious treatment of. IXC – iShares Global Energy ETF – Check IXC price, review total assets, see historical growth, and review the. ASX - By Stock. 1950. Created with Sketch. . Appreciate your input Dr T. ASX - Short Term Trading. ASX - General. , page-136. Charts. Maybe more common that what people think, imagine once GPs start diagnosing it even better if a treatment is developed, Prevalence could increase 2 or times which ultimately increases. Appendix 4E and Annual Report, page-3. Webinvest Pty Ltd<Olsb Unit A/C>. British Columbia, Selkirk Mountains. ASX - By Stock. Yet since market announcement of Phase 2 completion, this. . About 90 percent of the U. Backed by Twiggy. Share Well this is unexpected, for the first time ever for Invex, a director has purchased shares on-market. Market . ASX - By Stock. International Markets. ASX - Day Trading. ASX - Day Trading. Forums. . 91%) As of 03:35PM EST. A rolling snowball gathers snow as it falls down the hill . 54am 24/11/2023 ? HotCopper has news, discussion, prices and market data on INCA MINERALS LIMITED. For IXC I see the risk in one indication, comparatively lower TAM than others and different formulation for a week duration while phase II used daily. IXC Valuation Report MST. Created with Sketch. Latest Posts. Charts. STN Saturn Metals reports high-grade gold intersections and visible gold at Apollo Hill, WAInvex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical. Bumping up this thread as $3. Click for more information. But the market volume was very low, which points to a lack of interest, the long horizons of biotech, lack of publicising or Notification of cessation of securities - IXC. ASX - Day TradingI bought some today at 44. What would you like to pay the world leader in IIH science as CSO, and how much of that salary you would expect to be spent on market to buy shares? Hi All, Having scrolled through the IXC forum for 18-24 months now, I have seen quite literally 200+ posts of charts discussing the stock price, and only a handful of posts discussing the fundamental analysis of the business itself, Publication of Invex IIH Phase II Pressure Trial Results. 0. ASX - By Stock. Created with Sketch. This is a complete waste of time and posting space - give yourself a break man and forget about trying to predict what is completely un-predictable. ASX - By Stock. Im not expecting anything out of the ordinary apart from the fact thats its overdone and too undervalued at the stage its at. ASX - Day TradingQuarterly Activities/Appendix 4C Cash Flow ReportMarch 20 (Reuters) - Invex Therapeutics Ltd (IXC) : APPROVAL TO COMMENCE IIH EVOLVE PHASE III CLINICAL TRIAL RECEIVED FROM BUNDESINSTITUT FÜR. If nothing has occurred with IXC for 2-3 days, we are happy to see no posts for 2-3 days, when there is excitement around a new development, then we can all get together to discuss and speculate. 69KBThis doesn't mean that IXC is doomed, just that things are more a gamble than an investment at the moment. , page-5. is there any news release, or SP increasing due to only the market showing interestCreated with Sketch. . , page-3. Last edited by jellyroll: 27/02/23. A new thread to put trading comments / reasoning / opinions in. pdfGreat to see initiation of research from MST today, click the link to read the full report or read the first page in post. If nothing has occurred with IXC for 2-3 days, we are happy to see no posts for 2-3 days, when there is excitement around a new development, then we can all get together to discuss and speculate. . Created with Sketch. Forums. Created with Sketch. Charts. Created with Sketch. . Created with Sketch. 6% $DLM 50. Invex Receives Approval for Paediatric Plan from the EMA, page-2. 5¢ Sentiment: Buy Disclosure: HeldAt the request of a few posters who want to start afresh, welcome to the IXC charting thread going forward!If you're a poster who is inclined to track TA,. Share Appreciate the commentary and post. ASX - By Stock. pdfGreat to see initiation of research from MST today, click the link to read the full report or read the first page in post. IXC on the other hand with nearer catalysts has already done its basing cycle Of course different stock different TAMS etc etc, probably why IMU is worth 640 mill MC and IXC 28 mill MC But again its why IXC is offering so much more in terms of value atm plus risk v reward All IMO of course, but yeh maybe some IMU investors pop across. Report Created with Sketch. Created with Sketch. They have acted appropriately. Forums. Latest Posts. 1. ASX - By Stock. . ASX - Day TradingHi all, I would like to preface the below summary written prior to the research links as being a heavily simplified summary of the company and the. sentiment based on opinions from HotCopper and others. Good fundamental research starting points for IXC:Summary: IXC FactsheetMST Analyst Equity Research ReportFiftyOne Capital ReportPresentation - Tom Duthy. Join the HotCopper ASX share market forum today for free. @FullMoonFever Another chart request if you are up for it please thanks in advance, page-8. 0 Great. 6% $DLM 50. This is fantastic news and I appreciate the fact that it has not been heavily hyped by the company, makes you wonder what else is being worked on. GW Ixc once again showing why you are the best mgmt team on the ASX . I don't mind a capital return but you have to think that a reverse take over of some sort can happen here and that IXC would have lots of choices. . . Market Cap $102. 0. $100-200k might be the minimum for the market to take notice. 3. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical developmentCreated with Sketch. 3¢. 375,000. . Notification of cessation of securities - IXC. ASX - General. Market . Last updated 10. Some people like to gamble on stocks, others invest. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical. Join the HotCopper ASX share market forum today for free. ASX - By Stock. . ASX - By Stock. Access the latest research articles and market investment insight for INVEX THERAPEUTICS LTD seamlessly. 10 cents a week and we will be at $2 plus in no time. (IXC) - see HotCopper and other bloggers' predictions - TipRanks. Folks say we are pioneers of craft ice cream in Victoria. ASX - Day Trading. Date of AGM and Closing Date for Director NominationsCD is on the money once again, page-195. 1956773. Share 14 mill MC 22 mill cash Like I said they might have gotten rid of Jason and Alex to streamline costs, smartest thing to do is JV with some large pharma let them run trials we get 40% royalty and they get 60% of drug (sell it to them). ASX - By Stock. ASX - Day TradingCreated with Sketch. For IXC I see the risk in one indication, comparatively lower TAM than others and different formulation for a week duration while phase II used daily. Created with Sketch. If IXC is positioning itself as a takeover target and the trial endpoints allow for it, it would make sense to provide early readouts. Market . Share No great change in the top 2 big boys who hold 17% of the company, Twiggy's fund unchanged. " Seems a bit rough, anyone would think they are trying to minimise the number of SH who 'attend' the AGM. . Invex Therapeutics Ltd. . . Charts. Charts. . 30 to $15 in the space of 1 and half years Bios move fast when value is recognised. It was well aware of the claims made, released such information in the prospectus (and still had a hugely successful IPO), and would have done their due diligence before entering into any agreements with the University. In 2005, IIH cost the American health care. ASX - Day Trading. Trading HaltIXC Valuation Report MST. Created with Sketch. . Hopefully they hit the miracle, at least I get something back from this if it goes balls up which in the bio world at the moment is highly likely. Invex Therapeutics' Chief Scientific Officer, Professor Alexandra Sinclair, met with NASA's medical team. . 9 more clinical sites to be rapidly activated in a country with a growing incidence of IIH cases. , page-4. ASX - By Stock. Created with Sketch. Invex Therapeutics Limited (ASX:IXC) is a biopharmaceutical company focused on the repurposing of an already approved drug, Exenatide, for efficacious. ASX - Day TradingInvex Files Pre-IND/Type B Meeting Request with US FDA, page-2. Join HotCopper today. Notice of Annual General Meeting/Proxy FormInvex Receives Written Response from FDA on Type C MeetingNotification of cessation of securities - IXC. I think having this out we can discuss on the way. Join the HotCopper ASX share market forum today. 31% more bullish than other Healthcare sector stocks. , page-75. We are supported by a Board of Advice which is made up of the premier leaders in the various fields in which we, Private Capital Advisers, specialise. 0¢ Sentiment: Buy Disclosure: Held Bumping up this thread as $3. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical. ASX - General. com. Daily bounced well off support and now slowly creeping upId like to see a range develop now between say 18 - 23 before next bit of news, page-517. Created with Sketch. 1950. Interexchange Carrier, also known as IXC, is a telco that mainly provides long-distance communication services. pdfGreat to see initiation of research from MST today, click the link to read the full report or read the first page in post. . 05. Ionic Rare Earths Limited is an Australia-based company that is focused on investment in. Below is the broker data for IXC November to. IXC Valuation Report MST. , page-4. HotCopper has news, discussion, prices and market data on IXUP LIMITED. As thread states post your questions here and let’s start compiling a list. pause in tradingHere we go! AU and UK sites activated for immediate recruitment. Invex Files Pre-IND/Type B Meeting Request with US FDAIXC is a long term play mate, not a daytraders plaything as too illiquid. That is fair and as I mentioned in my initial post when buying, the business is worth the cash in ST. It certainly has been a hard few months for the biotech sector with PEB, NYR, NOX and now IXC all having prangs. They'll still have 14-15M in cash plus ODD for TBI in Europe and soon, one from the FDA, with plans for a P2 TBI study. 1. . *Close price adjusted for splits. ASX - By Stock. ASX - Day Trading. It was well aware of the claims made, released such information in the prospectus (and still had a hugely successful IPO), and would have done their due diligence before entering into any agreements with the University. Created with Sketch. But posts 3-4 times a day that are the same charts we can all see, about a -3% move on $10k volume, paired with hysteria and paranoia, its just not. Will management look for an early exit or are they wanting to take to market? Just came across IXC from another stock @JabraD posts on. With regard to costs, I'm encouraged by this statement in the release: Overall, the changes are expected to be cash neutral with respect to the original IIH EVOLVE trial costing, with recruitment anticipated to materially accelerate due to an expected significant reduction in pre-screen and screen failures. I'm thinking of flying there myself!Prof Alex Sinclair is to present in Melbourne and Sydney next. IXC Price at posting: 38. Jellyroll, arkangel, CD, balkanbroker to name a few have laid out some pretty compelling thesis' on where IXC will be heading. Appendix 4C - quarterlyAt the request of a few posters who want to start afresh, welcome to the IXC charting thread going forward!If you're a poster who is inclined to track TA,. , page-35. Created with Sketch. Invex Files Pre-IND/Type B Meeting Request with US FDA IXC is a long term play mate, not a daytraders plaything as too illiquid. Proposed Capital Return to Shareholders of $14. 0¢ Sentiment: Buy Disclosure: Held. Latest Posts. Notification of cessation of securities - IXC. . ASX - Short Term Trading. Withdrawal of AGM Resolutions, page-2. 5mill options have been issued at a strike price of $1 First lot 250k to a soph. We are a team of expert financial advisers each specialising in different, yet complementary areas. , page-4. 00 over the course of 2 years, and then doubled to $14 overnight on FDA approval. ASX - Day TradingA new thread to put trading comments / reasoning / opinions in. 1 Upvote. Hi Hot Copper, this will be a master thread for my daily posting of the Pharma Market Watchlist, please only keep commentary to the watchlist. Created with Sketch. Lots of possible reasons for this - but regardless, it points to Tom knowing that there is upside to this current SP. Last updated 10. 9MB OEC: 22/11/2023 1:05 PM : Cleansing Notice 2 pages 172. Update - Notification regarding unquoted securities - IXC. Market . 79 -0. 1. Appendix 4C - quarterly* or having a go at doing so, page-30. Charts. Plus, the opportunity to explore other conditions, including hydrocephalus and meningitis. Share Ok news not the greatest but I dont think its as bad as people gonna re-act (mainly retailers) Primary endpoint remains unchanged Protocol changes focus on reordering secondary endpoints - replacing PMD with the more. Created with Sketch. More progress made towards the start of Phase III, we have now made it on to the clinicltrials. ASX - By Stock. IXC could also be worth $14 on a successful trial and licensing deal (or takeover). Invex Granted Type C Meeting with FDA, page-2. Created with Sketch. is there any news release, or SP increasing due to only the market showing interestInvex Receives UK Approval to Commence Phase III TrialInvex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical. IXC Valuation Report MST. Created with Sketch. All IMO IXC Price at posting: 37. Market . You are the controller for IXC, you call the shots to make the company as best as possible for shareholders - this means retaining talent and forwarding the company to Phase III success and beyond. ASX - By Stock. . Ceasing to be a substantial holderAustralian finance news, stock quotes, currency information and blogsQuarterly Activities/Appendix 4C Cash Flow ReportInvex Granted European Patent for Exenatide in Hydrocephalus. 54pm 22/11/2023 ? HotCopper has news, discussion, prices and market data on INVEX THERAPEUTICS LTD. Notice of Investor Call and Presentation, page-2. It's essentially a cashed up shell company right now it. . 6million shares?, and if so is anyone worried about this, release date 29th. Thought that this would be worthy of its own thread, a great starting place for those new to IXC and arguably the best presentation to date, Worth a. ASX - General. Slow and steady with IXC. Last edited by ejjwj: 28/06/23. . wonder if the GLP-1 agonist referred to in this media release. Australia's largest stock trading and investment forum Australia's #1 stock forumInvex Successfully Concludes Protocol Assistance with EMA, page-2. Created with Sketch. Login to your CommSec account to buy. 20 to $7. Created with Sketch. Created with Sketch. ASX - Day Tradingis invex releasing 2. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical developmentHREC and TGA Approval to Commence Phase 3 in AustraliaHi guys, after discussion with Tom I have kind of mapped out the timeline to what is to be achieved. ASX - By Stock. ASX - By Stock. 1950. Also took placement stock @$1. 392 10/12/19 20:43 Post #: 41898691 Share @FullMoonFever Another chart request if you are up for it please thanks in advance IXC Valuation Report MST. 333334. 5¢ Sentiment: Buy Disclosure: Held Created with Sketch. I knew zero about the fundamentals of IXC. Australia's largest stock trading and investment forum Australia's #1 stock forumCreated with Sketch. Invex to Present at Virtual ASX Small and Mid-Cap ConferenceHealth & BiotechMay 24, 2020|Tim BorehamSHAREFrom the bulging file of Nasty Obscure Diseases we present idiopathic intracranial hypertension (IIH), a. Andrew Forrest , or his entities have been involved with IXC since inception. Share A few weeks ago in the lead up to the Phase 2 results invex included this slide on their slide deck - 'average 42 million increase in market cap after positive Phase 2 results'. Created with Sketch. ASX - By Stock. Australia's largest stock trading and investment forum Australia's #1 stock forumInvestor PresentationMRDMount Ridley Mines REE Project: Drilling confirms continuous high-grade mineralisation. 5¢ INVEX THERAPEUTICS LTD - Discussion. All the latest Invex Therapeutics Ltd (ASX:IXC) share price movements, news, expert commentary and investing advice from The Motley Fool Australia. , page-6. Update - Notification regarding unquoted securities - IXC. . Interexchange carriers (IXCs) own or share the various high-bandwidth, fiber-optic trunk lines that cross the country and provide high-speed switched digital services for voice, data, and video communication. Withdrawal of AGM ResolutionsInvex Granted Key European Patent for Exenatidehe’s known for the vend etc like asxcowboy has pointed out. ASX - Day TradingWith debt too expensive and lots of very discounted capital raisings especially in the microcap part of the market, I'd like to think that IXC can take advantage of the fact that they have cash. IXC (ASX) Ann: Trading Halt - HotCopper. Read in the announcement, has changed name and he has bought more ixc, page-2. ASX - Short Term Trading. 0¢ Sentiment: Buy Disclosure: Held. Created with Sketch. US data averaged $2314 per person in direct medical care, the total average direct cost per IIH admission was 4x that or $9256. is 19. Re-purposed FDA drug for other illness with amazing effect as domenstrated in P2 results which ever drove sp to $2. Given the quality of the posters on the IXC thread I am confident others will do the same. . Loading interactive chart. Hi All, I have decided to make an IXC broker data thread, as my PAR broker data thread was very well received. Market . Release Date: 21/11/22 08:18; Summary: First Patient Randomised in IIH EVOLVE Phase III Trial; Price Sensitive: Yes; Download Document 205. 54pm 22/11/2023 ? HotCopper has news, discussion, prices and market data on INVEX THERAPEUTICS LTD. Created with Sketch. . Friday we moved 55% off 690k volume. Forums. Appendix 4C - quarterly There are thousands of people out there with IXC shares, you simply can not predict when one is going to sell and how much they are going to sell. ASX - General. I guess that&amp;apos;s why retail performs so poorly on average, so many think they are long term investors but can&amp;apos;t hold onto their shares for more. 15M !Invex to Present at Bell Potter Healthcare ConferenceNotice of Annual General Meeting/Proxy Form, page-3. Invex Therapeutics Ltd. Forums. . Target our investor community with our suite of Hotcopper Advertising opportunities. You are the controller for IXC, you call the shots to make the company as best as possible for shareholders - this means retaining talent and forwarding the company to Phase III success and beyond. 10 Upvote. Created with Sketch. ASX - By Stock. ASX - Day Trading. . ASX - Day Trading. When can we expect some update or. AdINVEX THERAPEUTICS LTD (ASX:IXC) - IXC chart, page-1 - HotCopper | ASX Share Prices, Stock Market & Share Trading Forum Forums ASX - By Stock IXC. Appendix 4E and Annual Report, page-2. June 29 (Reuters) - Invex Therapeutics Ltd (IXC) : INVEX RECEIVES UK APPROVAL TO COMMENCE PHASE III TRIAL CLINICAL TRIAL FOR PRESENDIN DRUG FOR. . 59 before first real pull back (those lines will be used in the future, they always set it up for that reason, being $3. ASX - By Stock. Sentiment for Invex Therapeutics Ltd. 0 Great analysis. 147,415. ASX - Day TradingMEDSAFE and Ethics Approval for IIH EVOLVE Trial in NZCreated with Sketch. 375,000. ASX - Short Term Trading. 147,415. . ASX - By Stock. 4KB OECCreated with Sketch. A handy 10 bags from here with seemingly little risk. ASX - Day TradingNotice of Webinar &amp; Investor PresentationCreated with Sketch. Latest Posts. 0. All the latest Invex Therapeutics Ltd (ASX:IXC) share price movements, news, expert commentary and investing advice from The Motley Fool. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical. , page-4. ASX - Day TradingCreated with Sketch. ASX - Short Term Trading. Anyone buying now can carry to $5 and then sell a few prior to readout as insurance against losing everything in the coin flip. Invex Therapeutics Lists on ASX, page-3. Charts. 6 Upvote. ASX - Day TradingInvex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical.